Company page

Vaccinex, Inc.

Vaccinex, Inc. (ticker: VCNX) is a public company based in the United States with a market capitalization of approximately $2.97 million. The company focuses on developing innovative therapies for cancer and neurodegenerative diseases. Vaccinex aims to advance its research and product pipeline to address significant medical needs.